XFRA CAPITAL ADJUSTMENT INFORMATION

XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024

Das Instrument MSPA MA0000011488 ITISSALAT AL-MA. INH.DH 6 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument MSPA MA0000011488 ITISSALAT AL-MA. INH.DH 6 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument TG4 BE0003846632 OXURION N.V. EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument TG4 BE0003846632 OXURION N.V. EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument 5LH0 SE0021181559 GUARD THERAPEUTICS INT.AB EQUITY wird ex Kapitalmassnahme gehandelt am 02.09.2024
The instrument 5LH0 SE0021181559 GUARD THERAPEUTICS INT.AB EQUITY is traded ex capital adjustment on 02.09.2024

Das Instrument HQ10 US00211Y5069 ARCA BIOPHARMA DL-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument HQ10 US00211Y5069 ARCA BIOPHARMA DL-,01 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument FET KYG3307Z1090 FAR EAST CONS. INTL HD-10 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument FET KYG3307Z1090 FAR EAST CONS. INTL HD-10 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument 4QI KYG982771092 XTEP INTL HOL.REGS HD-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument 4QI KYG982771092 XTEP INTL HOL.REGS HD-,01 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument 6LJ US5768101058 MATINAS BIOPH.HLD.DL-,001 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument 6LJ US5768101058 MATINAS BIOPH.HLD.DL-,001 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument M5L GB00B0MT3Y97 MATTIOLI WOODS PLC LS-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument M5L GB00B0MT3Y97 MATTIOLI WOODS PLC LS-,01 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument EJ7 AU000000ERA9 ENERGY RES. A EQUITY wird ex Kapitalmassnahme gehandelt am 02.09.2024
The instrument EJ7 AU000000ERA9 ENERGY RES. A EQUITY is traded ex capital adjustment on 02.09.2024

Treibt Nvidias KI-Boom den Uranpreis?

In einer Welt, in der künstliche Intelligenz zunehmend zum Treiber technologischer Fortschritte wird, rückt auch der Energiebedarf, der für den Betrieb und die Weiterentwicklung von KI-Systemen erforderlich ist, in den Fokus.

Nvidia, ein Vorreiter auf dem Gebiet der KI, steht im Zentrum dieser Entwicklung. Mit steigender Nachfrage nach leistungsfähigeren KI-Anwendungen steigt auch der Bedarf an Energie. Uran, als Schlüsselkomponente für die Energiegewinnung in Kernkraftwerken, könnte dadurch einen neuen Stellenwert erhalten.

Dieser kostenlose Report beleuchtet, wie der KI-Boom potenziell den Uranmarkt beeinflusst und stellt drei aussichtsreiche Unternehmen vor, die von diesen Entwicklungen profitieren könnten und echtes Rallyepotenzial besitzen

Handeln Sie Jetzt!

Fordern Sie jetzt den brandneuen Spezialreport an und profitieren Sie von der steigenden Nachfrage, der den Uranpreis auf neue Höchststände treiben könnte.

Hier klicken

Zeit	Aktuelle Nachrichten
09.12.	ERA announces leadership changes amid Rio Tinto acquisition: Energy Resources of Australia (ERA) has announced leadership ...
08.12.	ENERGY RESOURCES OF AUSTRALIA LIMITED: Executive Leadership Updates
21.11.	ENERGY RESOURCES OF AUSTRALIA LIMITED: Change in substantial holding from RIO
21.11.	ENERGY RESOURCES OF AUSTRALIA LIMITED: Appendix 2A - application for quotation of securities
20.11.	Rio Tinto takes full control at Energy Resources of Australia

Zeit

Aktuelle Nachrichten

09.12.

ERA announces leadership changes amid Rio Tinto acquisition: Energy Resources of Australia (ERA) has announced leadership ...

08.12.

ENERGY RESOURCES OF AUSTRALIA LIMITED: Executive Leadership Updates

21.11.

ENERGY RESOURCES OF AUSTRALIA LIMITED: Change in substantial holding from RIO

21.11.

ENERGY RESOURCES OF AUSTRALIA LIMITED: Appendix 2A - application for quotation of securities

20.11.

Rio Tinto takes full control at Energy Resources of Australia

Zeit	Aktuelle Nachrichten
Fr	FE CONSORT INTL (00035): REQUEST FORM
Fr	FE CONSORT INTL (00035): LETTER TO THE NON-REGISTERED HOLDERS
Fr	FE CONSORT INTL (00035): CHANGE REQUEST FORM
Fr	FE CONSORT INTL (00035): LETTER TO THE SHAREHOLDERS
Fr	FE CONSORT INTL (00035): INTERIM REPORT 2024-2025

Zeit

Aktuelle Nachrichten

FE CONSORT INTL (00035): REQUEST FORM

FE CONSORT INTL (00035): LETTER TO THE NON-REGISTERED HOLDERS

FE CONSORT INTL (00035): CHANGE REQUEST FORM

FE CONSORT INTL (00035): LETTER TO THE SHAREHOLDERS

FE CONSORT INTL (00035): INTERIM REPORT 2024-2025

Zeit	Aktuelle Nachrichten
04.09.	Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of Guard Therapeutics International AB	With effect from September 05, 2024, the subscription rights in Guard Therapeutics International AB will be traded on First North Growth Market. Trading will continue up until and including September... ► Artikel lesen
02.09.	XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024	Das Instrument MSPA MA0000011488 ITISSALAT AL-MA. INH.DH 6 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024 The instrument MSPA MA0000011488 ITISSALAT AL-MA.... ► Artikel lesen
29.08.	Guard Therapeutics International AB: First patient dosed in Guard Therapeutics' phase 2b study POINTER	Guard Therapeutics today announced that the first patient has been dosed in the phase 2b clinical study POINTER with the drug candidate RMC-035 as a kidney-protective treatment in open-heart surgery. "It... ► Artikel lesen
27.08.	Guard Therapeutics International AB: Guard Therapeutics carries out announced rights issue (repair issue)	THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, DISTRIBUTED OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA... ► Artikel lesen

Zeit

Aktuelle Nachrichten

04.09.

Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of Guard Therapeutics International AB

With effect from September 05, 2024, the subscription rights in Guard Therapeutics International AB will be traded on First North Growth Market. Trading will continue up until and including September...
► Artikel lesen

02.09.

XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024

29.08.

Guard Therapeutics International AB: First patient dosed in Guard Therapeutics' phase 2b study POINTER

Guard Therapeutics today announced that the first patient has been dosed in the phase 2b clinical study POINTER with the drug candidate RMC-035 as a kidney-protective treatment in open-heart surgery. "It...
► Artikel lesen

27.08.

Guard Therapeutics International AB: Guard Therapeutics carries out announced rights issue (repair issue)

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, DISTRIBUTED OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA...
► Artikel lesen

Zeit	Aktuelle Nachrichten
02.09.	XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024		Das Instrument MSPA MA0000011488 ITISSALAT AL-MA. INH.DH 6 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024 The instrument MSPA MA0000011488 ITISSALAT AL-MA.... ► Artikel lesen
10.07.	The Court's Response to Maroc Telecom's Appeal Hinders the Success of e&'s Investments in Morocco		ABU DHABI, UAE, July 10, 2024 /PRNewswire/ -- e& Group has expressed its disappointment with the Court of Appeal of Casablanca's decision on 3 July 2024, which rejected the appeal filed by... ► Artikel lesen

Zeit

Aktuelle Nachrichten

02.09.

XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024

10.07.

The Court's Response to Maroc Telecom's Appeal Hinders the Success of e&'s Investments in Morocco

ABU DHABI, UAE, July 10, 2024 /PRNewswire/ -- e& Group has expressed its disappointment with the Court of Appeal of Casablanca's decision on 3 July 2024, which rejected the appeal filed by...
► Artikel lesen

Zeit	Aktuelle Nachrichten
27.11.	Matinas BioPharma Holdings, Inc. - 8-K, Current Report
13.11.	Matinas BioPharma Holdings, Inc. - 10-Q, Quarterly Report
06.11.	MTNB stock touches 52-week low at $0.5 amid sharp annual decline
06.11.	MTNB-Aktie erreicht 52-Wochen-Tief bei 0,5 US-Dollar
31.10.	Matinas BioPharma mulls wind-down as antifungal therapy deal falls through

Zeit

Aktuelle Nachrichten

27.11.

Matinas BioPharma Holdings, Inc. - 8-K, Current Report

13.11.

Matinas BioPharma Holdings, Inc. - 10-Q, Quarterly Report

06.11.

MTNB stock touches 52-week low at $0.5 amid sharp annual decline

06.11.

MTNB-Aktie erreicht 52-Wochen-Tief bei 0,5 US-Dollar

31.10.

Matinas BioPharma mulls wind-down as antifungal therapy deal falls through

Zeit	Aktuelle Nachrichten
19.11.	Mattioli Woods: Profit slashed at wealth manager as it quit London
04.09.	AIM - Cancellation - MATTIOLI WOODS PLC
03.09.	Mattioli Woods PLC - Scheme Effective
03.09.	AIM - Suspension - Mattioli Woods plc
02.09.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.09.2024	The following instruments on Boerse Frankfurt do have their last trading day on 02.09.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.09.2024ISIN NameBE0003846632 OXURION... ► Artikel lesen

Zeit

Aktuelle Nachrichten

19.11.

Mattioli Woods: Profit slashed at wealth manager as it quit London

04.09.

AIM - Cancellation - MATTIOLI WOODS PLC

03.09.

Mattioli Woods PLC - Scheme Effective

03.09.

AIM - Suspension - Mattioli Woods plc

02.09.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.09.2024

The following instruments on Boerse Frankfurt do have their last trading day on 02.09.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.09.2024ISIN NameBE0003846632 OXURION...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Do	Oruka Therapeutics, Inc.: Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody	Pharmacokinetic and safety data from healthy volunteers anticipated in the second half of 2025 On track to initiate a proof-of-concept study in psoriasis in the second half of 2025, with initial efficacy... ► Artikel lesen
Do	Oruka Therapeutics, Inc. - 8-K, Current Report
Mi	Oruka Therapeutics, Inc.: Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)	MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. ("Oruka") (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment... ► Artikel lesen
10.12.	Frazier Life Sciences Management L.P. Purchases New Position in Oruka Therapeutics, Inc. (NASDAQ:ORKA)
14.11.	Oruka Therapeutics, Inc. - 8-K, Current Report

Zeit

Aktuelle Nachrichten

Oruka Therapeutics, Inc.: Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody

Pharmacokinetic and safety data from healthy volunteers anticipated in the second half of 2025 On track to initiate a proof-of-concept study in psoriasis in the second half of 2025, with initial efficacy...
► Artikel lesen

Oruka Therapeutics, Inc. - 8-K, Current Report

Oruka Therapeutics, Inc.: Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)

MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. ("Oruka") (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment...
► Artikel lesen

10.12.

Frazier Life Sciences Management L.P. Purchases New Position in Oruka Therapeutics, Inc. (NASDAQ:ORKA)

14.11.

Oruka Therapeutics, Inc. - 8-K, Current Report

Zeit	Aktuelle Nachrichten
Do	OXURION: French Authorities Approve Oxurion's Strategic Transaction Under Specific Conditions	LEUVEN, BELGIUM - 19 December 2024 - 6:00PM, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces that the French Ministry of the Economy, Finance... ► Artikel lesen
12.12.	OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC	Leuven, BELGIUM - December 12, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen
09.12.	OXURION: Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC	Leuven, BELGIUM - December 9, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen
05.12.	OXURION: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas	Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital... ► Artikel lesen
02.12.	OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC	Leuven, BELGIUM - December 2, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen

Zeit

Aktuelle Nachrichten

OXURION: French Authorities Approve Oxurion's Strategic Transaction Under Specific Conditions

LEUVEN, BELGIUM - 19 December 2024 - 6:00PM, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces that the French Ministry of the Economy, Finance...
► Artikel lesen

12.12.

OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Leuven, BELGIUM - December 12, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen

09.12.

OXURION: Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC

Leuven, BELGIUM - December 9, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen

05.12.

OXURION: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital...
► Artikel lesen

02.12.

OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Leuven, BELGIUM - December 2, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Do	Xtep International Holdings goes ex dividend tomorrow
06.12.	XTEP INT'L (01368): ADJUSTMENT TO CONVERSION PRICE OF THE CONVERTIBLE BONDS
02.12.	XTEP INT'L (01368): PAYMENT OF SPECIAL DIVIDEND
02.12.	XTEP INT'L (01368): (1) COMPLETION OF DISPOSAL, ISSUE OF KP CONVERTIBLE BONDS AND GRANT OF WAIVER; (2) PAYMENT OF SPECIAL DIVIDEND; AND (3) CONTINUING ...
08.11.	Chinese sports brand Xtep debuts in Malaysia

Zeit

Aktuelle Nachrichten

Xtep International Holdings goes ex dividend tomorrow

06.12.

XTEP INT'L (01368): ADJUSTMENT TO CONVERSION PRICE OF THE CONVERTIBLE BONDS

02.12.

XTEP INT'L (01368): PAYMENT OF SPECIAL DIVIDEND

02.12.

XTEP INT'L (01368): (1) COMPLETION OF DISPOSAL, ISSUE OF KP CONVERTIBLE BONDS AND GRANT OF WAIVER; (2) PAYMENT OF SPECIAL DIVIDEND; AND (3) CONTINUING ...

08.11.

Chinese sports brand Xtep debuts in Malaysia

Unternehmen / Aktien	Kurs	%
ENERGY RESOURCES OF AUSTRALIA LIMITED	0,002	0,00 %
FAR EAST CONSORTIUM INTERNATIONAL LTD	0,104	+0,97 %
GUARD THERAPEUTICS INTERNATIONAL AB	1,520	-0,65 %
MAROC TELECOM	7,750	0,00 %
MATINAS BIOPHARMA HOLDINGS INC	0,054	0,00 %
MATTIOLI WOODS PLC	9,250	0,00 %
ORUKA THERAPEUTICS INC	19,500	0,00 %
OXURION NV	0,249	+3,75 %
XTEP INTERNATIONAL HOLDINGS LTD	0,705	0,00 %

Unternehmen / Aktien

Kurs

ENERGY RESOURCES OF AUSTRALIA LIMITED

0,002

0,00 %

FAR EAST CONSORTIUM INTERNATIONAL LTD

0,104

+0,97 %

GUARD THERAPEUTICS INTERNATIONAL AB

1,520

-0,65 %

MAROC TELECOM